Form 8-K - Current report:
SEC Accession No. 0001140361-25-040066
Filing Date
2025-11-03
Accepted
2025-11-03 06:09:11
Documents
15
Period of Report
2025-11-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ef20058056_8k.htm   iXBRL 8-K 36359
2 PRESS RELEASE OF BRISTOL-MYERS SQUIBB COMPANY ef20058056_ex99-1.htm EX-99.1 114670
7 image0.jpg GRAPHIC 334565
  Complete submission text file 0001140361-25-040066.txt   798046

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmy-20251103.xsd EX-101.SCH 4491
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20251103_def.xml EX-101.DEF 17941
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20251103_lab.xml EX-101.LAB 27064
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20251103_pre.xml EX-101.PRE 20183
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20058056_8k_htm.xml XML 7160
Mailing Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543
Business Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543 6092524621
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

EIN.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 251441985
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)